Author:
Ma Jiachun,Li Yan,Yu Hongxuan,Zhang Jingxin,Zhang Yanyan,Verma Vivek,Chen Hao,Qin Xiaohang,Zhai Xiaoqian,Shang Shijie,Shangguan Jian,Wang Ruiyang,Tian Chen,Wang Fei,Yu Jinming,Chen Dawei
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference38 articles.
1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023
2. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018
3. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer;Paz-Ares;N Engl J Med,2018
4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
5. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: A pooled analysis of two randomised trials;Theelen;Lancet Respir Med,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In Regard to J. Ma et al.;International Journal of Radiation Oncology*Biology*Physics;2024-07
2. In Reply to Z. Ma et al.;International Journal of Radiation Oncology*Biology*Physics;2024-07